1. Home
  2. TARA vs SHMD Comparison

TARA vs SHMD Comparison

Compare TARA & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARA
  • SHMD
  • Stock Information
  • Founded
  • TARA N/A
  • SHMD 1864
  • Country
  • TARA United States
  • SHMD Germany
  • Employees
  • TARA N/A
  • SHMD N/A
  • Industry
  • TARA Biotechnology: Biological Products (No Diagnostic Substances)
  • SHMD
  • Sector
  • TARA Health Care
  • SHMD
  • Exchange
  • TARA Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • TARA 118.1M
  • SHMD 112.0M
  • IPO Year
  • TARA N/A
  • SHMD N/A
  • Fundamental
  • Price
  • TARA $3.03
  • SHMD $2.56
  • Analyst Decision
  • TARA Strong Buy
  • SHMD
  • Analyst Count
  • TARA 7
  • SHMD 0
  • Target Price
  • TARA $20.67
  • SHMD N/A
  • AVG Volume (30 Days)
  • TARA 214.2K
  • SHMD 14.6K
  • Earning Date
  • TARA 08-11-2025
  • SHMD 02-25-2025
  • Dividend Yield
  • TARA N/A
  • SHMD N/A
  • EPS Growth
  • TARA N/A
  • SHMD N/A
  • EPS
  • TARA N/A
  • SHMD N/A
  • Revenue
  • TARA N/A
  • SHMD $85,165,542.00
  • Revenue This Year
  • TARA N/A
  • SHMD N/A
  • Revenue Next Year
  • TARA N/A
  • SHMD N/A
  • P/E Ratio
  • TARA N/A
  • SHMD N/A
  • Revenue Growth
  • TARA N/A
  • SHMD N/A
  • 52 Week Low
  • TARA $1.60
  • SHMD $1.86
  • 52 Week High
  • TARA $10.48
  • SHMD $4.40
  • Technical
  • Relative Strength Index (RSI)
  • TARA 44.29
  • SHMD N/A
  • Support Level
  • TARA $3.06
  • SHMD N/A
  • Resistance Level
  • TARA $3.33
  • SHMD N/A
  • Average True Range (ATR)
  • TARA 0.17
  • SHMD 0.00
  • MACD
  • TARA -0.01
  • SHMD 0.00
  • Stochastic Oscillator
  • TARA 4.65
  • SHMD 0.00

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: